• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1009542-23
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intimal Dissection (1333); Headache (1880); Pain (1994)
Event Date 01/07/2015
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2015, a 3.5x23mm xience v stent was implanted in the mid left anterior descending (lad) coronary artery.Following, a distal edge dissection was noted and treated with a 3.0x15mm xience v stent.Post procedure, the patient complained of non-cardiac chest pain and a headache.Medication was provided for both.Reportedly, the chest pain and headache were not serious.On (b)(6) 2015, the headache resolved without sequela and the patient was discharged home.There was no additional information provided.
 
Manufacturer Narrative
(b)(4).Lab data: (b)(6) 2015 (12:15): troponin i=0.005 ng/ml, upper reference limit 0.04; (b)(6) 2015: ck=42 u/l, normal upper limit 223; (b)(6) 2015: ck-mb=1.3 ng/ml, normal upper limit 5.0.It is indicated that the device is not returning for evaluation; therefore, a failure analysis of the complaint device could not be completed.A review of the lot history record revealed no non-conformances that would have contributed to the reported event.The reported patient effects of pain, headache and dissection, as listed in the xience v everolimus eluting coronary stent system electronic instructions for use (ifu) are known patient effects that may be associated with the use of coronary stents.Although a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency with respect to manufacturing, design or labeling.Based on the reviewed information, no product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key4443709
MDR Text Key5379325
Report Number2024168-2015-00367
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P070015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 01/09/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/22/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/09/2016
Device Catalogue Number1009542-23
Device Lot Number4013141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/09/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
Patient Weight120
-
-